ArticleBMJ open2019

Rationale and design of a prospective, multicentre, randomised, conventional treatment-controlled, parallel-group trial to evaluate the efficacy and safety of ulinastatin in preventing acute respiratory distress syndrome in high-risk patients.

Zongyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.